Medtech expected to bounce back after Q1 low
It is still not expected to reach the nearly $20 billion raised in 2021.
MedCity News‘ Katie Adams writes about a recent PitchBook analysis of the medtech sector, noting that the firm believes that funding reached its low point in the first quarter but will slowly pick back up over the rest of 2023.
PitchBook’s report suggests that this year’s medtech funding total will not come close to the $19.7 billion the sector raised in 2021, and it might even be lower than last year’s funding total of $13.5 billion. Both deal value and deal count increased in the second quarter of this year, and there was also a wider variety of medtech categories snagging large deals.
We found it interesting that the most active venture capital investor in the medtech field is the Maryland Technology Development Corporation, which has made six investments. Several investors have made five deals this year, including ShangBay Capital, SOSV, New Enterprise Associates, and the European Innovation Council Fund.